Fecal microbiota transplantation through colonoscopy for the management of severe refractory irritable bowel syndrome: Preliminary results
Recent studies have explored the role of the microbiota in disorders of gut-brain interaction, opening pathways for therapies, such as dietary adjustments, probiotics, and fecal microbiota transplantation (FMT). We present herein a pilot study on 4 patients with severe irritable bowel syndrome (IBS), refractory to conventional treatment, in which FMT through colonoscopy showed improvement in pain, bloating, and stool consistency that was maintained during the 6-month follow-up. To establish the broader clinical application of FMT, more research on its efficacy according to instillation site and patient results is needed.
Authors
- K. Herrera (ORCID: https://orcid.org/0009-0007-6024-337X)
- Paulina Núñez (ORCID: https://orcid.org/0000-0003-3727-1851)
- Christian von Mühlenbrock (ORCID: https://orcid.org/0000-0001-5285-1147)
- Rodrigo Quera (ORCID: https://orcid.org/0000-0001-5854-0526)
- Neith Pacheco (ORCID: https://orcid.org/0000-0002-4637-2657)
Institutions
- Universidad de Los Andes, Chile (CL)
Publication Details
- Journal
- Revista de Gastroenterología de México (English Edition)
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1016/j.rgmxen.2025.03.001
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00